Fortis Healthcare Schedules Board Meeting and Conference Call for Q3FY26 Results

2 min read     Updated on 06 Feb 2026, 01:45 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Fortis Healthcare Limited has announced comprehensive arrangements for Q3FY26 financial results presentation, including a board meeting on February 13, 2026, and a subsequent conference call on February 16, 2026, at 11:00 AM IST with detailed dial-in information for domestic and international participants.

31911358

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare Limited has formally notified stock exchanges about comprehensive arrangements for its quarterly financial performance review. The healthcare major will present its third-quarter results to investors and stakeholders through multiple engagement channels following regulatory compliance procedures.

Board Meeting Details

The company has scheduled a Board of Directors meeting for Friday, February 13, 2026, with a specific agenda to consider and approve crucial financial documents. The meeting will focus on reviewing comprehensive financial performance across different business segments.

Meeting Parameter: Details
Date: February 13, 2026
Purpose: Consider and approve Q3FY26 unaudited financial results
Reporting Period: Quarter and period ended December 31, 2025
Results Type: Standalone and Consolidated

Conference Call Schedule

Following the board meeting, Fortis Healthcare Limited has arranged a conference call to discuss the financial results with investors and analysts. The virtual meeting will provide detailed insights into the company's quarterly and nine-month performance.

Conference Call Details: Information
Date: February 16, 2026
Time: 11:00 AM IST
Mode: Virtual Conference Call
Purpose: Discuss Q3FY26 and 9MFY26 unaudited financial results
Type: Group Call

Dial-in Information

The company has provided comprehensive dial-in details for both domestic and international participants to ensure broad accessibility for the conference call.

Participant Region: Dial-in Number Local Time
India Primary: +91 22 6280 1307 / 7115 8208 11:00 AM
UK (Toll Free): 0 808 101 1573 05:30 AM
US NY (Toll Free): 1 866 746 2133 12:30 AM
Singapore (Toll Free): 800 101 2045 01:30 PM
Hong Kong (Toll Free): 800 964 448 01:30 PM

Trading Window Restrictions

In accordance with regulatory compliance requirements, Fortis Healthcare Limited has implemented mandatory trading restrictions for company securities. The trading window closure ensures fair market practices during the financial results announcement period.

Trading Window Details: Information
Status: Closed
Duration: Until 48 hours after results announcement
Closure End Date: February 15, 2026
Reference Letter: FHL/SEC/2025-26 dated December 22, 2025

Regulatory Compliance

The board meeting and conference call notifications have been issued in strict compliance with Securities and Exchange Board of India regulations. The company has fulfilled its disclosure obligations under multiple regulatory frameworks to ensure transparency in corporate governance. The notifications were filed under Regulation 29, 30, and 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.09%+1.69%-6.44%-1.32%+27.89%+411.31%

Fortis Healthcare Completes Postal Ballot for Director Appointment with Overwhelming Shareholder Approval

2 min read     Updated on 23 Jan 2026, 04:26 PM
scanx
Reviewed by
Suketu GScanX News Team
Overview

Fortis Healthcare Limited concluded its postal ballot on January 22, 2026, with 99.39% shareholder approval for appointing Mr. Mohd Shahazwan Bin Mohd Harris as Non-Independent & Non-Executive Director. The process saw 86.73% overall participation with 654,756,573 valid votes cast, demonstrating strong corporate governance compliance under SEBI LODR regulations.

30711363

*this image is generated using AI for illustrative purposes only.

Fortis Healthcare Limited has successfully completed its postal ballot voting process, securing overwhelming shareholder approval for a key board appointment. The healthcare major announced the results on January 23, 2026, following the conclusion of voting on January 22, 2026.

Resolution Outcome

The postal ballot addressed a single resolution regarding the appointment of Mr. Mohd Shahazwan Bin Mohd Harris (DIN: 08465456) as a Non-Independent & Non-Executive Director of the Company, liable to retire by rotation. The resolution received strong shareholder support with the following results:

Voting Result: Votes Percentage
Votes in Favor: 650,781,446 99.39%
Votes Against: 3,975,127 0.61%
Total Valid Votes: 654,756,573 100.00%

Voting Process and Compliance

The postal ballot process was conducted in strict compliance with the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, and the Companies Act, 2013. CS Mukesh Kumar Agarwal from Mukesh Agarwal & Co. served as the appointed scrutinizer to ensure transparency and fairness in the voting process.

The company dispatched the postal ballot notice electronically to all eligible shareholders on December 23, 2025, with the record date set as December 19, 2025. Shareholders had multiple voting options available:

  • Electronic voting through KFin Technologies Limited's platform
  • Physical postal ballot forms submitted via registered email
  • Voting period from December 23, 2025, to January 22, 2026

Shareholder Participation Details

The voting process witnessed significant participation across different shareholder categories:

Category: Shares Held Votes Polled Participation Rate
Promoter and Promoter Group: 235,295,895 235,295,895 100.00%
Public Institutions: 421,096,628 379,699,808 90.17%
Public Non-Institutions: 98,565,625 39,760,870 40.34%
Total: 754,958,148 654,756,573 86.73%

The promoter and promoter group demonstrated complete support with 100% participation and unanimous approval. Public institutions showed strong engagement with over 90% participation, while retail investors participated at 40.34% rate.

Regulatory Framework and Documentation

The postal ballot process adhered to multiple regulatory frameworks including MCA General Circulars and SEBI circulars issued between 2020-2025. The company published mandatory advertisements in Financial Express (English) and Rozana Spokesman (Punjabi) on December 24, 2025, ensuring proper disclosure to all stakeholders.

KFin Technologies Limited facilitated the electronic voting infrastructure, maintaining secure systems for vote casting and tabulation. The scrutinizer's report confirmed that all procedural requirements were met, with votes unblocked on January 22, 2026, at 17:18 hours in the presence of independent witnesses.

Corporate Governance Impact

The successful completion of this postal ballot demonstrates Fortis Healthcare's commitment to transparent corporate governance practices. The appointment of Mr. Mohd Shahazwan Bin Mohd Harris as a Non-Independent & Non-Executive Director will contribute to the company's board composition and strategic oversight capabilities. The resolution was deemed passed on January 22, 2026, being the last date for vote casting, and will be formally recorded in the company's board minutes.

Historical Stock Returns for Fortis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.09%+1.69%-6.44%-1.32%+27.89%+411.31%

More News on Fortis Healthcare

1 Year Returns:+27.89%